Drug-Induced Osmotic Nephropathy: Add SGLT2-Inhibitors to the List?
Perazella MA, Juncos LA.
Kidney360. 2021 Dec 21;3(3):550-553. doi: 10.34067/KID.0007882021. eCollection 2022 Mar 31.
Feline ureteral obstructions Part 1: medical management.
Clarke DL.
J Small Anim Pract. 2018 Jun;59(6):324-333. doi: 10.1111/jsap.12844. Epub 2018 May 16.
Osmotic polyuria: an overlooked mechanism in diabetic nephropathy.
Wang S, Mitu GM, Hirschberg R.
Nephrol Dial Transplant. 2008 Jul;23(7):2167-72. doi: 10.1093/ndt/gfn115. Epub 2008 May 2.
Green nephrology.
Barraclough KA, Agar JWM.
Nat Rev Nephrol. 2020 May;16(5):257-268. doi: 10.1038/s41581-019-0245-1. Epub 2020 Feb 7.
Drug-induced nephropathy: an update.
Perazella MA.
Expert Opin Drug Saf. 2005 Jul;4(4):689-706. doi: 10.1517/14740338.4.4.689.
Understanding hypernatremia.
Sam R, Feizi I.
Am J Nephrol. 2012;36(1):97-104. doi: 10.1159/000339625. Epub 2012 Jun 27.
Nephrotic edema.
De Santo NG, Pollastro RM, Saviano C, Pascale C, Di Stasio V, Chiricone D, Cirillo E, Molino D, Stellato D, Frangiosa A, Favazzi P, Capodicasa L, Bellini L, Anastasio P, Perna A, Sepe J, Cirillo M.
Semin Nephrol. 2001 May;21(3):262-8. doi: 10.1053/snep.2001.21654.
Pathophysiology of contrast-induced nephropathy.
Wong PC, Li Z, Guo J, Zhang A.
Int J Cardiol. 2012 Jul 12;158(2):186-92. doi: 10.1016/j.ijcard.2011.06.115. Epub 2011 Jul 23.
Albumin metabolism.
Rothschild MA, Oratz M, Schreiber SS.
Gastroenterology. 1973 Feb;64(2):324-37.
Osmolality.
Warhol RM, Eichenholz A, Mulhausen RO.
Arch Intern Med. 1965 Nov;116(5):743-9. doi: 10.1001/archinte.1965.03870050097014.
